|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5310 EUR | -4.67% |
|
+1.34% | -65.43% |
| 07-13 | AB Science to Discontinue Three Masitinib-related Clinical Studies | MT |
| 07-10 | AB Science streamlines its portfolio and refocuses on two molecules |  |
MarketScreener Strategies
Search
No results match your criteria
- Stock Market
- Stocks
- AB Stock
- News AB Science
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
